Back to Authors

Iida, Taku

https://orcid.org/0000-0002-4207-2577

Mayo Clinic

Kyoto University Hospital

Citations 1

How Do Transplant Surgeons Accomplish Optimal Portal Venous Flow During Living-Donor Liver Transplantation? Noninvasive Measurement of Indocyanine Green Elimination Rate
Hori, Tomohide , Ogura, Yasuhiro , Yagi, Shintaro , Iida, Taku , Taniguchi, Kentaro, Moghazy, Walid M. El, Hedaya, Mohammed, Segawa, Hajime, Ogawa, Kohei , Kogure, Takayuki , Üemoto, Shinji

Surgical Innovation | May 23, 2013 | Volume: 21 | Issue: 1 | Pages: 43-51

10.1177/1553350613487803 Get It

Background. Balancing donor safety and graft volume is difficult. We previously reported that intentional modulation of portal venous pressure (PVP) during living-donor liver transplantation (LDLT) is crucial to overcoming problems with small-for-size grafts; however, detailed studies of portal venous flow (PVF) and a reliable parameter are still required. Patients and Methods. The elimination rate ( k) of indocyanine green (ICG) was measured in 49 adult LDLT recipients. PVP was controlled during LDLT, with a target of <20 mm Hg. ICG reflects hepatocyte volume and effective PVF. The kICG value is divided by the graft weight to calculate PVF. Recipients were divided into 2 groups: those with severe and/or fatal complications within 1 month after LDLT and those without. Results. Survival rates and postoperative profiles were significantly different between the 2 groups. Univariate analysis showed significant differences in ABO blood group, final PVP, final kICG, and the final kICG/graft weight value; however, multivariate analysis showed that only the kICG/graft weight value was significant. The cutoff level for the final kICG/graft weight value for predicting successful LDLT was 3.1175 × 10 −4 /g. Conclusion. Accurate evaluation and monitoring of optimal PVF during LDLT should overcome the use of small-for-size grafts and improve donor safety and recipient outcomes.